Clinical Trial Update: A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a zoster vaccine in healthy adults aged 40 and older (Phase 1/Phase 2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Herpes Zoster | Phase 1, Phase 2 | Status: COMPLETED